Growth Metrics

Teladoc Health (TDOC) Depreciation & Amortization (CF) (2016 - 2025)

Teladoc Health (TDOC) has disclosed Depreciation & Amortization (CF) for 12 consecutive years, with $2.8 million as the latest value for Q4 2025.

  • Quarterly Depreciation & Amortization (CF) fell 6.04% to $2.8 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $13.3 million through Dec 2025, up 30.75% year-over-year, with the annual reading at $13.3 million for FY2025, 30.75% up from the prior year.
  • Depreciation & Amortization (CF) hit $2.8 million in Q4 2025 for Teladoc Health, up from $2.6 million in the prior quarter.
  • In the past five years, Depreciation & Amortization (CF) ranged from a high of $94.3 million in Q3 2023 to a low of $1.7 million in Q2 2024.
  • Historically, Depreciation & Amortization (CF) has averaged $36.3 million across 5 years, with a median of $50.0 million in 2021.
  • Biggest five-year swings in Depreciation & Amortization (CF): soared 418.96% in 2021 and later tumbled 97.74% in 2024.
  • Year by year, Depreciation & Amortization (CF) stood at $52.3 million in 2021, then surged by 44.68% to $75.7 million in 2022, then tumbled by 96.31% to $2.8 million in 2023, then grew by 6.7% to $3.0 million in 2024, then fell by 6.04% to $2.8 million in 2025.
  • Business Quant data shows Depreciation & Amortization (CF) for TDOC at $2.8 million in Q4 2025, $2.6 million in Q3 2025, and $4.3 million in Q2 2025.